Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
Go back to Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1107.08 +5.00 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 256.27 | |||
| Day Low | $1079.22 | EPS | $4.32 | |||
| Volume | 3,310,261 | |||||
